Sinovac Biotech EPS of $0.02, beats on revenues

|About: Sinovac Biotech, Ltd. (SVA)|By:, SA News Editor

Sinovac Biotech (SVA): Q2 EPS of $0.02 beats by $0.08.

Revenue of $17.5M (+86.4% Y/Y) beats by $5.88M. (PR)